Xeris Biopharma Holdings (XERS) Net Equity Issued and Repurchased (2021 - 2022)

Xeris Biopharma Holdings (XERS) posted Net Equity Issued and Repurchased of $30.0 million for Q1 2022, up 11.11% on a QoQ basis from $27.0 million in Q1 2021, and up 11.11% year-over-year from $27.0 million in Q1 2021.

Xeris Biopharma Holdings (XERS) Net Equity Issued and Repurchased (2021 - 2022) Analysis & Trends

Xeris Biopharma Holdings' Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $30.0 million for Q1 2022.

  • Quarterly Net Equity Issued and Repurchased rose 11.11% year-over-year to $30.0 million in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $30.0 million (up 11.11% YoY) and the FY2022 annual result came in at $30.0 million, up 11.11% from the prior year.
  • Net Equity Issued and Repurchased was $30.0 million for Q1 2022 at Xeris Biopharma Holdings, up from $27.0 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $30.0 million in Q1 2022 and bottomed at $27.0 million in Q1 2021.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 500,000.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Xeris Biopharma Holdings 1.43 Bn 1.32 Bn 72.55 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 30.00 Mn
Mar 31, 2022 30.00 Mn
Mar 31, 2021 27.00 Mn
Mar 31, 2021 27.00 Mn